AzTrials
AzTrials

PeriodontitisNCT07668947

Impact of E-Cigarette Smoking on Healing Response to Non-Surgical Periodontal Therapy

A study testing non surgical periodontal therapy in people with Periodontitis, run by Ain Shams University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

the goal of this clinical trial is to compare the effect of vaping vs traditional smoking on non surgical periodontal therapy . the main question it aims to answer is what is the impact of traditional smoking and vaping on periodontal health and how do IL-1B and IL-20 serve as mediators in the inflammatory processes… Read more about this study

Who is it for?
Ages 20 to 40 years
Conditions the study is for
Periodontitis
What is being tested?
non surgical periodontal therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
117 participants
Where
1 siteEgypt
Study dates
13 Oct 2025to 4 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • pts aged 20-40 years
  • pts with stage II periodontitis
  • systemically healthy with no chronic diseases
  • no current use of medication
  • participants have the same socioeconomic status
  • participants must be able to understand and comply with the study protocol and give informed consent

Who cannot join

  • pts with severe systemic diseases
  • recent use of immunosuppressants or medications that affect oral health
  • history of illicit drug use within the past 12 months
  • periodontal surgery or scaling within the last 6 months
  • participants in another clinical trial
  • vulnerable individuals as children and pregnant

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • faculty of dentistry , Ain shams university

    Cairo, Cairo Governorate, 11566

Other trials in Egypt

About this study

Official title: Impact of E-Cigarette Smoking on Healing Response to Non-Surgical Periodontal Therapy in the Management of Stage II Periodontitis (A Randomized Controlled Clinical Study With Biochemical Assessment )

the goal of this clinical trial is to compare the effect of vaping vs traditional smoking on non surgical periodontal therapy . the main question it aims to answer is what is the impact of traditional smoking and vaping on periodontal health and how do IL-1B and IL-20 serve as mediators in the inflammatory processes linked to periodontal disease?

Read the detailed description

the goal of this clinical trial is to compare the effect of vaping vs traditional smoking on non surgical periodontal therapy . the main question it aims to answer is what is the impact of traditional smoking and vaping on periodontal health and how do IL-1B and IL-20 serve as mediators in the inflammatory processes linked to periodontal disease? .A randomized controlled clinical trial will be conducted on patients with periodontitis stage II . participants will be allocated to one of three groups: traditional smokers , vapers and non-smokers . the randomization process will ensure unbiased distribution of participants across the groups . periodontal health will be evaluated through clinical assesment ( probing depth as primary outcome, clinical attachemt level, bleeding on probing and GI ) then cytokine levels (IL-1B , IL-20) will be assessed.

Conditions
Periodontitis
Being tested
non surgical periodontal therapy
Keywords
periodontitis, smoking, e-cigarette, GCF
Medical subject headings
Periodontitis, Smoking, Vaping

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • non surgical periodontal therapyProcedure or surgery

    participants in all groups will recieve non surgical periodontal therapy including scaling and root planning performed using ultrasonic and hand instruments at baseline. oral hygiene instructions will be provided. periodontal parameters and GCF samples will be collected at baseline and follow up visit.

Study groups in NCT07668947
Study groupRoleWhat they receive
traditional smokersActive comparatorpatients with stage II periodotitis who are conventional cigarette smokers and recieved non surgical periodontal therapy
Receives: Procedure: non surgical periodontal therapy
e-cigarette smokersActive comparatorpts with stage II periodontitis who are on e-cigarette smoking and recieved non surgical periodontal therapy
Receives: Procedure: non surgical periodontal therapy
non smokersActive comparatorpts with stage II periodontitis who are non smokers and recieved non surgical periodontal therapy
Receives: Procedure: non surgical periodontal therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. probing depth (PD)

    assessment of periodontal probing depth measured in millimeters using a UNC -15 periodontal probe. PD will be measured from the gingival margin to the base of the periodontal pocket at six sites per tooth

    Measured: baseline and 2 months follow up

  2. clinical attachment loss

    assessment of CAL measured in millimeters using a UNC-15 periodontal probe. CAL will be measured from (CEJ) to the base of the pocket at 6 sites per tooth

    Measured: baseline and 2 months follow up after non surgical periodontal surgery

  3. plaque index

    assessment of plaque accumulation using plaque index ( Silness and Loe plaque index )

    Measured: baseline and 2 months follow up after NSPT

  4. bleeding on probing

    assessment of gingival bleeding following periodontal probing and recorded as the percentage of bleeding sites.

    Measured: baseline and 2 months follow up after NSPT

Secondary outcomes (2)
  1. interleukin-1B level in GCF

    assessment of IL-1B level in GCF using ( ELISA ). results will be expressed according to assay manufacturer's instructions

    Measured: baseline and 2 months after NSPT

  2. IL-20 level in GCF

    assessment of IL-20 levels in GCF samples using (ELISA ). results will be expressed according to assay manufacturer's instructions

    Measured: baseline and 2 month after NSPT

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2026
  2. Study start13 Oct 2025
  3. Primary completion21 Dec 2025
  4. Study completion4 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
117 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07668947
Sponsor's protocol ID
1449
Status last verified
Jun 2026
First submitted
16 Jun 2026
Last updated
1 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD will not be shared to protect participant confidentiality and due to ethical considerations. only summarized and deidentified data will be published

Questions about this trial

What is this clinical trial studying?

A study testing non surgical periodontal therapy in people with Periodontitis, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

probing depth (PD) (time frame: baseline and 2 months follow up). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in